Modelling the therapeutic dose range of single low dose primaquine to reduce malaria transmission through age-based dosing

BACKGROUND: Low-dose primaquine is a key candidate for use in malaria transmission reduction and elimination campaigns such as mass drug administration (MDA). Uncertainty about the therapeutic dose range (TDR) required for general and paediatric populations challenge the implementation of the World...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Daniel Joseph, Banda, Clifford George, Chipasula-Teleka, Alexandra, Terlouw, Dianne Janette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385020/
https://www.ncbi.nlm.nih.gov/pubmed/28390397
http://dx.doi.org/10.1186/s12879-017-2378-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385020/
https://www.ncbi.nlm.nih.gov/pubmed/28390397
http://dx.doi.org/10.1186/s12879-017-2378-9

Ejemplares similares